Showing results (181-190 of 398) with videos related to
Sort By:
Pageof 40
Genome Medicine|May 29, 2020
Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patientHye Won Lee, Woosung Chung, Hae-Ock Lee, et al.Investigational New Drugs|September 10, 2013
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patientsSu Jin Lee, Jongtae Lee, Jeeyun Lee, et al.The Korean Journal of Internal Medicine|September 11, 2010
Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancerJunshik Hong, Sun Young Kyung, Sang Pyo Lee, et al.Cancer Research and Treatment|January 18, 2019
Atezolizumab in Patients with Pretreated Urothelial Cancer: a Korean Single-Center, Retrospective StudyJoon Young Hur, Youjin Kim, Ghee-Young Kwon, et al.Annals of Surgical Oncology|December 6, 2013
CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancerSang Yun Ha, In-Gu Do, Jeeyun Lee, et al.Micromachines|June 26, 2026
Process Integration and Reliability Challenges of Through-Glass Vias for Glass-Based Advanced Packaging: A Focused ReviewDong Bae Park, Jinho Jo, Seonwoo Kim, et al.Journal of Cancer|July 11, 2019
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancerYoujin Kim, Sun-Ju Byeon, Joonyoung Hur, et al.Clinical Colorectal Cancer|March 20, 2018
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory CancerJeeyun Lee, Seung Tae Kim, Sungju Park, et al.Medical Oncology (Northwood, London, England)|November 7, 2008
Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tractJung Yong Hong, Moon Ki Choi, Ji Eun Uhm, et al.Translational Oncology|June 9, 2016
BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma CellsHee Kyung Kim, Sun Young Kim, Su Jin Lee, et al.Pageof 40